Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease

NCT01846689 is registered in ClinicalTrials.gov with Targeted Medical Pharma as lead sponsor.

NCT NCT01846689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease
Lead sponsor
Targeted Medical Pharma
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2013
Completion date
September 30, 2013
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia of chronic disease